Purpura fulminans is a critical, mostly fatal, thrombotic syndrome that requires urgent intervention. Purpura fulminans is an acute purpuric rash characterized by coagulation of the microvasculature, which leads to purpuric lesions and skin necrosis. In this report, we present a rare case of an adult patient who was admitted with rapidly forming purpura fulminans in an uncommon location.
Introduction
Purpura fulminans is considered one of the fatal thrombotic disorders that requires immediate diagnosis and management. It is an acute purpuric rash characterized by coagulation of the microvasculature, which leads to purpuric lesions and skin necrosis. Purpura fulminans is rapidly progressive and is often accompanied by disseminated intravascular coagulation and circulatory collapse. It can be inherited or acquired and can occur in neonates, children, and adults. There are three forms of this disease with a classification scheme based on the triggering mechanism: inherited abnormalities of protein C or other coagulation systems, acute infectious purpura fulminans, and idiopathic [1] . In this report, we present a rare case of an adult patient who was admitted with acute infectious purpura fulminans in an uncommon location.
Case Report
A 75-year-old male was presented to the emergency department with a decreased level of consciousness associated with a skin lesion over the nose for 1 day. He had a past medical history of myelofibrosis.
Dermatological examination showed a nonblanching violaceous ecchymosis with localized central early skin necrosis on the tip of the nose (Fig. 1a, b) .
Our initial differential diagnosis included purpura fulminans, warfarin-induced skin necrosis, levamisole-contaminated cocaine-induced necrosis or vasculitis, lupus pernio, and cryoglobulinemia.
There was no history of exposure to warfarin or levamisole-contaminated cocaine, and the cryoglobulin test was negative. Other laboratory results are shown in Table 1 .
The blood cultures grew methicillin-resistant Staphylococcus aureus. The combination of clinical presentation and laboratory results led to the diagnosis of purpura fulminans.
On the second day of the clinical course, skin lesions progressed rapidly to a sharply delineated full-thickness necrosis over the patient's entire nasal region (Fig. 2a, b) . His clinical course was complicated by disseminated intravascular coagulation, which required the transfusion of blood products, along with ventilatory support for hypoxic respiratory failure and inotropes for controlling the acute heart failure. He also developed acute renal failure, which required hemodialysis. By the end of the second day, the patient had passed away.
Discussion
The term "purpura fulminans" was first used in the late 1800s to describe a syndrome of extensive purpura in severely ill patients, usually children, in the setting of an acute or convalescent infection [1] . Purpura fulminans is a rare, life-threatening condition characterized by disseminated intravascular coagulation, with extensive tissue thrombosis and hemorrhagic skin necrosis. Purpura fulminans that is caused by heterozygous protein C deficiency with venous thromboembolism usually does not have disseminated intravascular coagulation as a component of its pathogenesis [1] .
Purpura fulminans begins with erythema, which develops irregular central areas of blueblack hemorrhagic necrosis. The distribution of purpura fulminans lesions may be different according to the underlying pathogenesis. Purpura fulminans in severe sepsis is typically developed in the distal extremities and progresses proximally, or it appears as a generalized or diffuse purpuric rash affecting the whole body surface. In reviewing the literature, there are very few cases of purpura fulminans that occur over the nose. All of them are summarized in Table 2 [2] [3] [4] [5] [6] [7] [8] . A case of purpura fulminans that occurred over the nose was first described in 1986 [2] . It was a case of rhinocerebral mucormycosis for an infant with streptococcal sepsis and purpura fulminans [2] . In 1989, Har-El et al. [3] described a case of purpura fulminans of the head and neck secondary to pneumococcal sepsis in a splenectomized patient. In 2006, Duteille et al. [4] reported a case of a 5-year-old boy who underwent subtotal amputation of the nose after meningococcus-induced purpura fulminans. Urushidate et al. [5] performed nose and upper lip reconstruction on a 48-year-old male patient, following left cerebellopontine angle tumor excision, who suffered from purpura fulminans after sepsis due to Klebsiella pneumoniae. Pei Chia Eng et al. [6] published a very challenging case of purpura fulminans which involved the tip of the nose and was caused by Capnocytophaga septicemia following a dog bite. The patient was diagnosed by a blood film [6] . The most recent case of purpura fulminans that involved the nose was published in February 2017 [7] . It was one of the rare causes of purpura fulminans associated with a paraneoplastic syndrome in a patient with mesothelioma who was receiving chemotherapy [7] . All the previous cases of purpura fulminans have involved the nose, in addition to the distal extremities. However, in contrast to all previous studies, our case presented with isolated purpura fulminans over the nose. To our knowledge, the only published case of a similar presentation was caused by septic abortion [8] .
Conclusion
Purpura fulminans is a life-threatening thrombotic disorder that requires immediate diagnosis and management. It is rare to present with an isolated lesion to one site of the body, as discussed in this case. An isolated necrotic skin lesion over the nose does not exclude the diagnosis of purpura fulminans, especially when it is presented with septicemia and disseminated intravascular coagulation. This highlights the importance of adding purpura fulminans to the differential diagnosis of skin necrosis over the nose, such as warfarin-induced skin necrosis, levamisole-contaminated cocaine-induced necrosis, and cryoglobulinemia.
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The manuscript is the original work of all authors. All authors made a significant contribution to this study. All authors have read and approved the final version of the manuscript. Fig. 1. a, b On the first day, nonblanching violaceous ecchymosis was seen with localized central early skin necrosis on the tip of the nose. Fig. 2. a, b On the second day, sharply delineated full-thickness necrosis was seen over the patient's entire nasal region. 
